search
Back to results

The Use of Aromatherapy for Symptom Management

Primary Purpose

Nausea, Vomiting and Anxiety Associated With Medical Oncology Patients

Status
Unknown status
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Peppermint and Lavender Essential Oils
Sponsored by
Central DuPage Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Nausea, Vomiting and Anxiety Associated With Medical Oncology Patients

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Adult hospitalized medical oncology patients admitted to Central DuPage Hospital.
  • Age 18 years or greater.
  • Able to understand and speak English.
  • Women of non-childbearing potential or with childbearing potential with a negative pregnancy test documented during the hospital stay.
  • Able to understand concept of aromatherapy for treatment of distressing symptoms.

Exclusion Criteria:

  • Prisoners.
  • Non-English speaking patients.
  • Under the age of 18.
  • Unable to comprehend the concept of aromatherapy.
  • Severe cognitive impairment.
  • Not experiencing the symptoms of nausea, vomiting or anxiety.
  • Women with child-bearing potential who have not had a negative pregnancy test during the hospital stay.
  • Patients with known allergy to lavender or peppermint.

Sites / Locations

  • Central DuPage HospitalRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Peppermint and Lavender Essential Oils

Arm Description

Outcomes

Primary Outcome Measures

Post Intervention Patient Interview Form

Secondary Outcome Measures

Full Information

First Posted
June 11, 2014
Last Updated
February 3, 2015
Sponsor
Central DuPage Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT02163369
Brief Title
The Use of Aromatherapy for Symptom Management
Official Title
The Use of Aromatherapy for Symptom Management
Study Type
Interventional

2. Study Status

Record Verification Date
February 2015
Overall Recruitment Status
Unknown status
Study Start Date
July 2014 (undefined)
Primary Completion Date
June 2015 (Anticipated)
Study Completion Date
undefined (undefined)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Central DuPage Hospital

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this pilot study is to introduce the use of aromatherapy/essential oils to medical oncology patients at Central DuPage Hospital to assess their perceived effectiveness to relieve symptoms of nausea or vomiting and/or anxiety. Peppermint oil will be used for nausea/vomiting and lavender oil will be used for anxiety. This study will involve administration of aromatherapy to a convenience sample of patients, who will then be asked to complete a brief questionnaire. The questionnaire will involve a simple likert scale to measure efficacy (in the opinion of the patient) and simple multiple-choice questions to determine patients' likeliness to use aromatherapy again.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Nausea, Vomiting and Anxiety Associated With Medical Oncology Patients

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
40 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Peppermint and Lavender Essential Oils
Arm Type
Experimental
Intervention Type
Drug
Intervention Name(s)
Peppermint and Lavender Essential Oils
Primary Outcome Measure Information:
Title
Post Intervention Patient Interview Form
Time Frame
24hrs post aromatherapy

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Adult hospitalized medical oncology patients admitted to Central DuPage Hospital. Age 18 years or greater. Able to understand and speak English. Women of non-childbearing potential or with childbearing potential with a negative pregnancy test documented during the hospital stay. Able to understand concept of aromatherapy for treatment of distressing symptoms. Exclusion Criteria: Prisoners. Non-English speaking patients. Under the age of 18. Unable to comprehend the concept of aromatherapy. Severe cognitive impairment. Not experiencing the symptoms of nausea, vomiting or anxiety. Women with child-bearing potential who have not had a negative pregnancy test during the hospital stay. Patients with known allergy to lavender or peppermint.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Mary Lyons, MSN, APN/CNS, RN-BC, ONC
Phone
630-933-6011
Email
mary.lyons@cadencehealth.org
First Name & Middle Initial & Last Name or Official Title & Degree
Lorraine Mack, MSN, RN, CNL, OCN
Phone
630-933-3413
Email
lorraine.mack@cadencehealth.org
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mary Lyons, MSN, APN/CNS, RN-BC, ONC
Organizational Affiliation
Central DuPage Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Central DuPage Hospital
City
Winfield
State/Province
Illinois
ZIP/Postal Code
60190
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Mary Lyons, MSN, APN/CNS, RN-BC ONC
Phone
630-933-6011
First Name & Middle Initial & Last Name & Degree
Lorraine Mack, RN
Phone
630-933-3413

12. IPD Sharing Statement

Learn more about this trial

The Use of Aromatherapy for Symptom Management

We'll reach out to this number within 24 hrs